Kardigan
KARD20.5000.69% ( +0.140 )
Kardigan (KARD)
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfoli...
- Open
- 20.360
- High
- 21.420
- Low
- 20.250
- Prev. Close
- 20.360
- Volume
- 160.05K
- Turnover
- 3.31M
- Avg Price
- 20.666
- Bid/Ask Ratio
- --
- Amplitude
- 5.75%
- 52wk High
- 27.000
- Volume Ratio
- 0.78
- Turnover Ratio
- 0.34%
Kardigan Analyst Rating
View MoreForecast & Rating
Jul 31, 2026Price forecast
$43.50112.20%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Jul 21 at 12:20 AM
Kardigan, Inc.'s (NASDAQ:KARD) Quiet Period To End on July 28th
- Market Beat · Jul 16 at 06:40 AM
Kardigan, Inc. (NASDAQ:KARD) Short Interest Up ∞ in June
- benzinga_article · Jul 13 at 06:41 AM
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- benzinga_article · Jun 30 at 07:05 AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- PUBT · Jun 24 at 03:19 PM
ARCH Venture Fund XIII acquires $20 million of Kardigan common shares
- PUBT · Jun 23 at 05:06 AM
Kardigan bylaws add advance notice rules for shareholder proposals, board nominees
